US FDA declines to approve Outlook Therapeutics' drug for eye condition-February 2024-www.financetom.com

US FDA declines to approve Outlook Therapeutics' drug for eye condition

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA declines to approve Outlook Therapeutics' drug for eye condition

Aug 28, 2025 3:58 AM

Aug 28 (Reuters) - The U.S. Food and Drug Administration

has declined to approve Outlook Therapeutics' ( OTLK )

experimental drug to treat a type of eye condition that causes

blurred vision, the company said on Thursday.

Previous page： Danaher Unit Cepheid Reportedly Urged to Cut Mpox Test Prices for Better Access Next page： Salesforce Says Service Outage Prevents End Users From Accessing Platform

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Danaher Unit Cepheid Reportedly Urged to Cut Mpox Test Prices for Better Access

Nov 15, 2024

08:13 AM EST, 11/15/2024 (MT Newswires) -- Danaher's ( DHR ) Cepheid subsidiary is being urged by global health groups to reduce the price of its GeneXpert mpox test to $5 from $20 to improve access in low-income nations, media outlets reported Friday. The World Health Organization declared mpox a global public health emergency this summer as an outbreak in...

Salesforce Says Service Outage Prevents End Users From Accessing Platform

Nov 15, 2024

07:30 AM EST, 11/15/2024 (MT Newswires) -- Salesforce ( CRM ) said Friday it is experiencing a service outage that began at 05:55 UTC. The Salesforce Services are experiencing a service disruption affecting multiple instances, preventing end users from accessing the platform, the company said on its website. Salesforce ( CRM ) said its technology team is still reviewing the...

Rescinding US EV tax credit would cede ground to China, Granholm says

Nov 15, 2024

BAKU (Reuters) - Cancelling the U.S. electric vehicle tax credit would be counterproductive and cede ground to car-makers in China, U.S. Energy Secretary Jennifer Granholm told reporters on Friday at the COP29 climate conference in Baku. President-elect Donald Trump's transition team is planning to kill the $7,500 consumer tax credit as part of broader tax-reform legislation, Reuters reported Thursday. It...

Disney nears tipping point as streaming profits start to offset cable decline

Nov 15, 2024

By Aditya Soni and Jaspreet Singh Nov 15 (Reuters) - Bob Iger returned to Walt Disney ( DIS ) as CEO in 2022 with a bold promise of making streaming profitable. The latest quarterly results have shown signs of a turnaround at the storied media company, suggesting that Iger may be getting the House of Mickey Mouse in order by...